The AccuType® CP, Clopidogrel CYP2C19 Genotype test contains 1 test with 1 biomarker.
Clopidogrel (Plavix®) is metabolized by CYP2C19 to its active form. This assay detects loss-of-function variants in the CYP2C19 gene leading to reduced therapeutic response to Clopidogrel treatment.
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
AccuType® CP, Clopidogrel CYP2C19 Genotype #16924
1 Biomarkers - Specimen Type: Blood
Also known as: AccuType CP Clopidogrel CYP2C19 Genotype
Biomarkers 1
Accutype(R) Cp,
*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.